Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.9B | 6.0B | 4.0B | 4.2B |
Cost of revenue | 4.7B | 5.0B | 3.1B | 3.3B |
Gross profit | 1.3B | 1.0B | 862M | 880M |
Operating expense | ||||
Research & development | 435M | 369M | 203M | 207M |
Selling general and admin | 559M | 580M | 466M | 477M |
Other operating expenses | — | — | — | — |
Operating income | 278M | 93M | 193M | 196M |
Non operating interest income | ||||
Income | 21M | 2M | 3M | 10M |
Expense | 97M | 64M | 83M | 85M |
Other income expense | — | — | — | — |
Pretax income | 186M | -532M | 89M | 103M |
Tax provision | 95M | 343M | 96M | 64M |
Net income | 91M | -875M | -7M | 40M |
Basic EPS | 0.1 | — | 0.0 | 0.0 |
Diluted EPS | 0.1 | — | 0.0 | 0.0 |
Basic average shares | 922.2M | — | 650M | 825M |
Diluted average shares | 922.2M | — | 650M | 825M |
EBITDA | 634M | 510M | 410M | 431M |
Net income from continuing op. | 263M | -469M | 170M | 178M |
Minority interests | -7M | -7M | -6M | -7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |